How to manage withdrawal of glucocorticoid therapy

@article{Iliopoulou2013HowTM,
  title={How to manage withdrawal of glucocorticoid therapy},
  author={A. Iliopoulou and A. Abbas and R. Murray},
  journal={Prescriber},
  year={2013},
  volume={24}
}
Our series on stopping drugs provides practical advice on why, when and how to withdraw drug therapy. Here the authors discuss the issues arising from discontinuing glucocorticoid therapy. 
A Case Report of Steroid Withdrawal Syndrome
TLDR
A 74-year-old woman who presented with non-specific symptoms of lethargy, malaise, and poor oral intake with weight loss for 1 month, and investigations showed suboptimal 9 AM cortisol level has responded well to steroid replacement. Expand
An Approach to Minimising Risk of Adrenal Insufficiency When Discontinuing Oral Glucocorticoids
TLDR
An approach that dermatologists can use to minimise the risk of adrenal insufficiency in patients discontinuing glucocorticoids and when it may be appropriate to use adrenal gland testing is provided. Expand
Glucocorticoid Tapering: a Literature Review
TLDR
In this article, this article will discuss how to manage GCs tapering and when is the right time to use GCs. Expand
BTS Clinical Statement on pulmonary sarcoidosis
This British Thoracic Society (BTS) Clinical Statement addresses the diagnosis, evaluation and management of pulmonary sarcoidosis, with each section summarised with key clinical practice points. InExpand
PREDICTING RECOVERY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER PROLONGED GLUCOCORTICOID USE.
TLDR
Early morning ambulatory cortisol could be used to decide on timely SST in order to prevent complications from unnecessary replacement with glucocorticoids. Expand
What we have to know about corticosteroids use during Sars-Cov-2 infection
TLDR
This review summarizes the available data on HPA axis impairment in GC-treated SARS-CoV-2 patients, focusing on the risk of adrenal insufficiency and on potential drug interactions during concomitant treatments. Expand